Jacot W, Lusque A, Vicier C, Mailliez A, et al. Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations. Br J Cancer 2022 Oct 7. pii: 10.1038/s41416-022-02003.
PMID: 36207609